Inloggen
E-mail
Wachtwoord
Paswoord weergeven
Bewaren
Bent u uw wachtwoord vergeten?
Gratis lid worden
Registreer
Registreer
Instellingen
Instellingen
Dynamische koersen 
OFFON

Toonaangevende leiders

Alle informatieOndernemingenMarktenEconomie & ForexgrondstoffenRenteToonaangevende leidersFinanciŽle professionalAgendaSectoren 
HomepaginaAl het nieuwsHet meest gelezen nieuwsBiografieŽn van de Leiders
Portrait de David M. Tanen
Leeftijd : 48
Vermogen : 19 152 472 USD
Belangrijkste bedrijven : Kronos Bio, Inc. - Allogene Therapeutics, Inc.
Overzicht 
Founder of 6 different companies, including: Kite Pharma, Inc., Allogene Therapeutics, Inc. and Arno Therapeutics, Inc. David M. Tanen is an entrepreneur and currently holds the position of Director, Vice President & Managing Member at Two River Group Management LLC, Partner at Two River Group Holdings LLC (which he founded in 2011), Director & Senior Managing Director at Riverbank Capital Securities, Inc. (a subsidiary of Two River Group Holdings LLC), Secretary at Allogene Therapeutics, Inc. (which he founded in 2007) and Secretary & Director at Neogene Therapeutics, Inc.

He is also on the board of Danube Pharmaceuticals, Inc. and Kronos Bio, Inc. and Director & Senior Managing Director at Riverbank Capital Securities, Inc., Managing Member at Two Rivers Consulting Corp. and Partner at Two River Consulting LLC (he founded the company).

Mr. Tanen previously was Secretary & Director at Arno Therapeutics, Inc. (he founded the company in 2000) and Secretary for Arno Therapeutics, Inc. (a subsidiary of Arno Therapeutics, Inc.), Secretary at Capricor Therapeutics, Inc. and Secretary at Nile Therapeutics, Inc. (a subsidiary of Capricor Therapeutics, Inc.), General Partner of Orion Biomedical Fund LP and Secretary & General Counsel for Kite Pharma, Inc. (he founded the company).

Mr. Tanen received an undergraduate degree from George Washington University and a graduate degree from Fordham University School of Law.


Posities en verantwoordelijkheden van David M. Tanen 
NaamTitel Van
Kronos Bio, Inc.
(Biotechnologie & Medisch Onderzoek)
Director -
Allogene Therapeutics, Inc.
(Biotechnologie & Medisch Onderzoek)
Secretary -
Riverbank Capital Securities, Inc. Director & Senior Managing Director 2013
Danube Pharmaceuticals, Inc. Director 1996
Two River Group Management LLC Director, Vice President & Managing Member -
Neogene Therapeutics, Inc. Secretary & Director 2018
Kirax Corp. Co-Founder 2005
Two Rivers Consulting Corp. Managing Member -
Two River Consulting LLC Partner -
Two River Group Holdings LLC Co-Founder & Partner 2011


Belangnemingen van David M. Tanen 
NaamAandelen%Totale waarde
Kronos Bio, Inc. (KRON)
(Biotechnologie & Medisch Onderzoek)
913 7631,62%19 152 472 USD


David M. TanenPersoonlijk netwerk 
Meest gelezen nieuws 
15/10JACK DORSEY : Square CEO Dorsey zegt op zoek te zijn naar een bitcoin mining systeem - tweet
MR
12/10CATHIE WOOD : ARK Invest's Wood waarschuwt dat aanstaande economische neergang in China 'evident' is
MR
12/10JAMIE DIMON : JPMorgan's Dimon blaast bitcoin af als 'waardeloos', toe aan regulering
MR
13/10WARREN BUFFETT : Door Buffett gesteunde Nubank maakt winst in Brazilië
MR
11/10JAMIE DIMON : JPMorgan's Dimon blaast bitcoin af als 'waardeloos'
MR
07/10ROBERT WALTERS : Recruiter Robert Walters verwacht dat winst hoger zal uitvallen dan ramingen in warme banenmarkt
MR
06/10CARL ICAHN : Dominion verkoopt Questar aan Southwest Gas in een deal van bijna $2 miljard
MR
20/10PETER WENNINK : Resultaten ASML in de prik
AM
01:00ELON MUSK : Geen Elon Musk Show tijdens dit Tesla kwartaalgesprek
MR
20/10BILL GATES : Biotalys krijgt financiering van Bill Gates
AM
Meer nieuws


© 2021 People and Ownership :   
David M. Tanen Verbindingen